These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30879361)

  • 1. Evidence Supporting the Blood Pressure Treatment Goal of Less Than 130/80 mm Hg.
    Reboussin DM; Carey RM; Whelton PK
    Hypertension; 2019 May; 73(5):972-974. PubMed ID: 30879361
    [No Abstract]   [Full Text] [Related]  

  • 2. Can we justify goal blood pressure of <140/90 mm Hg in most hypertensives?
    Townsend RR
    Curr Hypertens Rep; 2005 Aug; 7(4):257-64. PubMed ID: 16061043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and Safety of Intensive Blood Pressure Therapy Using Restricted Mean Survival Time-Insights from the SPRINT Trial.
    Krishnaswami A; Peterson ED; Kim DH; Goyal P; Rich MW
    Am J Med; 2020 Jul; 133(7):e369-e370. PubMed ID: 32061731
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduction of blood pressure variability: a new strategy for the treatment of hypertension.
    Su DF; Miao CY
    Trends Pharmacol Sci; 2005 Aug; 26(8):388-90. PubMed ID: 15990175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brachial-brachial index of systolic blood pressure in the patients under anti-hypertensive therapy.
    Sun H; Li P; Su H; Wang W; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Jul; 174(3):802-4. PubMed ID: 24814541
    [No Abstract]   [Full Text] [Related]  

  • 6. How far should blood pressure be lowered? What is the role of the J-curve?
    Hansson L
    Am J Hypertens; 1990 Sep; 3(9):726-9; discussion 730-2. PubMed ID: 2222981
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated: Con Side of the Argument.
    Lurbe E; Redon J
    Hypertension; 2016 Aug; 68(2):276-80. PubMed ID: 27324227
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Con Side of the Argument.
    Kaul S
    Hypertension; 2020 Nov; 76(5):1391-1399. PubMed ID: 32951473
    [No Abstract]   [Full Text] [Related]  

  • 9. Adherence to Antihypertensive Treatment and the Blood Pressure-Lowering Effects of Renal Denervation in the Renal Denervation for Hypertension (DENERHTN) Trial.
    Azizi M; Pereira H; Hamdidouche I; Gosse P; Monge M; Bobrie G; Delsart P; Mounier-Véhier C; Courand PY; Lantelme P; Denolle T; Dourmap-Collas C; Girerd X; Michel Halimi J; Zannad F; Ormezzano O; Vaïsse B; Herpin D; Ribstein J; Chamontin B; Mourad JJ; Ferrari E; Plouin PF; Jullien V; Sapoval M; Chatellier G;
    Circulation; 2016 Sep; 134(12):847-57. PubMed ID: 27576780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension.
    Pettinger WA
    J Cardiovasc Pharmacol; 2017 Mar; 69(3):129-139. PubMed ID: 28267687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [24-hour automated recording of blood pressure in the diagnosis and treatment of arterial hypertension].
    Kabat M; Puciłowska B; Paschalis-Purtak K
    Kardiol Pol; 1992 Sep; 37(9):165-70. PubMed ID: 1479775
    [No Abstract]   [Full Text] [Related]  

  • 12. The blood pressure measurement--revisited.
    Safar ME; Smulyan H
    Am Heart J; 2006 Sep; 152(3):417-9. PubMed ID: 16923406
    [No Abstract]   [Full Text] [Related]  

  • 13. Of Signal and Noise: Overcoming Challenges in Blood Pressure Measurement to Optimize Hypertension Care.
    Muldoon MF; Kronish IM; Shimbo D
    Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004543. PubMed ID: 29748355
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument.
    Carey RM; Whelton PK
    Hypertension; 2020 Nov; 76(5):1384-1390. PubMed ID: 32951472
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood pressure variability: an additional target for antihypertensive treatment?
    Schillaci G; Pucci G; Parati G
    Hypertension; 2011 Aug; 58(2):133-5. PubMed ID: 21747045
    [No Abstract]   [Full Text] [Related]  

  • 16. Arterial stiffness: a tool to tailor antihypertensive therapy.
    Narain VS; Puri A
    Indian Heart J; 2008; 60(6):578-83. PubMed ID: 19276500
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view.
    Wright JT; Fine LJ; Lackland DT; Ogedegbe G; Dennison Himmelfarb CR
    Ann Intern Med; 2014 Apr; 160(7):499-503. PubMed ID: 24424788
    [No Abstract]   [Full Text] [Related]  

  • 18. [Resistant hypertension - progress in diagnosis and treatment].
    Szwench E; Florczak E; Prejbisz A; Kądziela J; Witkowski A; Januszewicz A
    Kardiol Pol; 2012; 70(1):66-74. PubMed ID: 22267432
    [No Abstract]   [Full Text] [Related]  

  • 19. Trough: peak ratio and smoothness index for antihypertensive agents.
    Meredith PA
    Blood Press Monit; 1999 Oct; 4(5):257-62. PubMed ID: 10547647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive treatment: is blood pressure-lowering the only goal?
    Zanchetti A
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S48-50. PubMed ID: 1726007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.